Alnylam Pharmaceuticals, Inc. <ALNY.O>: H.C. Wainwright cuts target price to $455 from $485
ALNY•Related News
AI cloud startup Volta valued at $2.4 billion, announces $10 billion AI partnership
BTDR•
Moderna publishes transcript of Q2 2026 earnings call
MRNA•
Coventry First U.S. Court Orders Unsealing Of Key Documents In Coventry-Abacus Global Management Litigation
ABL•
Vodafone PDMR Auramo sells shares worth GBP 917,277.91 to cover tax withholding obligations
VOD•
Stellantis’ Dodge stages Roadkill Nights Powered by Dodge press reveal, horsepower festival
STLA•